↓ Skip to main content

Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-ye…

Overview of attention for article published in SpringerPlus, January 2014
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
15 Mendeley